Skip to content
PICO Portalanswers from OpenAlex

<i>EGFR</i> Mutations in Lung Cancer: Correlation with Clinical Response to Gefitinib Therapy

PaperCitations, authors & open-access status

<i>EGFR</i> Mutations in Lung Cancer: Correlation with Clinical Response to Gefitinib Therapy is a paper indexed in PICO Portal from OpenAlex.

How many citations does <i>EGFR</i> Mutations in Lung Cancer: Correlation with Clinical Response to Gefitinib Therapy have?

PICO Portalcitation count

<i>EGFR</i> Mutations in Lung Cancer: Correlation with Clinical Response to Gefitinib Therapy has 9,435 citations in the OpenAlex counts PICO Portal stores.

When was <i>EGFR</i> Mutations in Lung Cancer: Correlation with Clinical Response to Gefitinib Therapy published?

PICO Portalyear

<i>EGFR</i> Mutations in Lung Cancer: Correlation with Clinical Response to Gefitinib Therapy has 2004 year in the PICO Portal index.

What is the open-access status of <i>EGFR</i> Mutations in Lung Cancer: Correlation with Clinical Response to Gefitinib Therapy?

PICO Portaloa status

<i>EGFR</i> Mutations in Lung Cancer: Correlation with Clinical Response to Gefitinib Therapy has closed oa status in the PICO Portal index.

What is the DOI of <i>EGFR</i> Mutations in Lung Cancer: Correlation with Clinical Response to Gefitinib Therapy?

PICO Portaldoi

The DOI for <i>EGFR</i> Mutations in Lung Cancer: Correlation with Clinical Response to Gefitinib Therapy is on the source record.

What is the PMID of <i>EGFR</i> Mutations in Lung Cancer: Correlation with Clinical Response to Gefitinib Therapy?

PICO Portalpmid

The PMID for <i>EGFR</i> Mutations in Lung Cancer: Correlation with Clinical Response to Gefitinib Therapy is on the source record.

What is the OpenAlex record for <i>EGFR</i> Mutations in Lung Cancer: Correlation with Clinical Response to Gefitinib Therapy?

PICO Portalopenalex

The OpenAlex for <i>EGFR</i> Mutations in Lung Cancer: Correlation with Clinical Response to Gefitinib Therapy is on the source record.

Related on PICO Portal

470M+ articles · 14-day free trial